Cargando…

Screening accuracy of a 14-day smartphone ambulatory assessment of depression symptoms and mood dynamics in a general population sample: Comparison with the PHQ-9 depression screening

INTRODUCTION: Major depression affects over 300 million people worldwide, but cases are often detected late or remain undetected. This increases the risk of symptom deterioration and chronification. Consequently, there is a high demand for low threshold but clinically sound approaches to depression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burchert, Sebastian, Kerber, André, Zimmermann, Johannes, Knaevelsrud, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787464/ https://www.ncbi.nlm.nih.gov/pubmed/33406120 http://dx.doi.org/10.1371/journal.pone.0244955

Ejemplares similares

PHQ-9 and PHQ-2 for Screening Depression in Chinese Rural Elderly
por: Liu, Zi-wei, et al.
Publicado: (2016)

Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia
por: Rancans, Elmars, et al.
Publicado: (2018)

The validity and reliability of the PHQ-9 in screening for post-stroke depression
por: Dajpratham, Piyapat, et al.
Publicado: (2020)

Depression screening in HIV-positive Tanzanian adults: comparing the PHQ-2, PHQ-9 and WHO-5 questionnaires
por: Nolan, C. P., et al.
Publicado: (2018)

Comparison of the Usefulness of the PHQ-8 and PHQ-9 for Screening for Major Depressive Disorder: Analysis of Psychiatric Outpatient Data
por: Shin, Cheolmin, et al.
Publicado: (2019)

Comparison of PHQ-9 and PHQ-2 as Screening Tools for Depression and School Related Stress in Inner City Adolescents
por: Anand, Paridhi, et al.
Publicado: (2021)

Screening for depression in primary care: a Rasch analysis of the PHQ-9
por: Horton, Mike, et al.
Publicado: (2016)

Effects of a Self-Guided Transdiagnostic Smartphone App on Patient Empowerment and Mental Health: Randomized Controlled Trial
por: Kerber, André, et al.
Publicado: (2023)

The cost-effectiveness of PHQ screening and collaborative care for depression in New York City
por: Jiao, Boshen, et al.
Publicado: (2017)

Validity of the patient health questionnaires (phq-2 and phq-9) for screening depression among human immunodeficiency virus patients in Lahore, Pakistan
por: Junaid, Khunsa, et al.
Publicado: (2022)

The Validity and Reliability of the PHQ-9 and PHQ-2 on Screening for Major Depression in Spanish Speaking Immigrants in Chile: A Cross-Sectional Study
por: Errazuriz, Antonia, et al.
Publicado: (2022)

Cognitive testing of the PHQ-9 for depression screening among pregnant and postpartum women in Kenya
por: Velloza, Jennifer, et al.
Publicado: (2020)

The validity and reliability of the PHQ-9 on screening of depression in neurology: a cross sectional study
por: Sun, Yajing, et al.
Publicado: (2022)

The Effect of COVID-19 Lockdown on PHQ Depression Screening Scores for High School Athletes
por: Adams, Devin P., et al.
Publicado: (2022)

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis
por: Levis, Brooke, et al.
Publicado: (2019)

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis
Publicado: (2019)

Validity, Reliability, and Optimal Cut-off Scores of the WHO-5, PHQ-9, and PHQ-2 to Screen Depression Among University Students in Iran
por: Ghazisaeedi, Marjan, et al.
Publicado: (2021)

Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics
por: van Steenbergen-Weijenburg, Kirsten M, et al.
Publicado: (2010)

Process evaluation of the Getting it Right study and acceptability and feasibility of screening for depression with the aPHQ-9
por: Farnbach, Sara, et al.
Publicado: (2019)

Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study
por: Arrieta, Jafet, et al.
Publicado: (2017)

Screening for depression: The added value of actigraphy and smartphone-based intensive sampling of depressive affect and behaviors
por: Minaeva, O., et al.
Publicado: (2021)

‘Optimal’ cutoff selection in studies of depression screening tool accuracy using the PHQ‐9, EPDS, or HADS‐D: A meta‐research study
por: Brehaut, Eliana, et al.
Publicado: (2022)

People with diabetes need a lower cut-off than others for depression screening with PHQ-9
por: Cichoń, Ewelina, et al.
Publicado: (2020)

Screening for depression as part of annual diabetic review using PHQ-9 scores: a pilot study
por: Asim, Rabeeah, et al.
Publicado: (2023)

Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies
por: Mitchell, Alex J., et al.
Publicado: (2016)

Utility of PHQ-2, PHQ-8 and PHQ-9 for detecting major depression in primary health care: a validation study in Spain
por: Gómez-Gómez, Irene, et al.
Publicado: (2023)

PHQ-9 DIAGNOSTIC ACCURACY AND OPTIMAL CUT-OFF FOR DEPRESSION AMONG PATIENTS WITH STROKE IN NIGERIA
por: Okeafor, I.N., et al.
Publicado: (2023)

Brief Depression Screening with the PHQ-2 Associated with Prognosis Following Percutaneous Coronary Intervention with Paclitaxel-Eluting Stenting
por: Pedersen, Susanne S., et al.
Publicado: (2009)

Screening for Major Depressive Disorder with the Patient Health Questionnaire (PHQ-9 and PHQ-2) in an Outpatient Clinic Staffed by Primary Care Physicians in Japan: A Case Control Study
por: Suzuki, Keiko, et al.
Publicado: (2015)

Passive Sensing of Prediction of Moment-To-Moment Depressed Mood among Undergraduates with Clinical Levels of Depression Sample Using Smartphones
por: Jacobson, Nicholas C., et al.
Publicado: (2020)

PHQ-8 Days: a measurement option for DSM-5 Major Depressive Disorder (MDD) severity
por: Dhingra, Satvinder S, et al.
Publicado: (2011)

Validation of the Patient Health Questionnaire (PHQ-9) as a screening tool for depression in pregnant women: Afaan Oromo version
por: Woldetensay, Yitbarek Kidane, et al.
Publicado: (2018)

Screening male prisoners for depression and anxiety with the PHQ-9 and GAD-7 at NHS Healthcheck: patterns of symptoms and caseness threshold
por: Butcher, Elizabeth, et al.
Publicado: (2021)

The Value of Chinese Version GAD-7 and PHQ-9 to Screen Anxiety and Depression in Chinese Outpatients with Atypical Chest Pain
por: Lin, Qiuzhen, et al.
Publicado: (2021)

Utilizing a Personal Smartphone Custom App to Assess the Patient Health Questionnaire-9 (PHQ-9) Depressive Symptoms in Patients With Major Depressive Disorder
por: Torous, John, et al.
Publicado: (2015)

Mood and Activity Measured Using Smartphones in Unipolar Depressive Disorder
por: Tønning, Morten Lindbjerg, et al.
Publicado: (2021)

Does app-based unguided self-management improve mental health literacy, patient empowerment and access to care for people with mental health impairments? Study protocol for a randomised controlled trial
por: Kerber, André, et al.
Publicado: (2021)

The Influence of Current Mood States on Screening Accuracy of the Mood Disorder Questionnaire
por: Wang, Hee Ryung, et al.
Publicado: (2020)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

Comparing the factor structures and reliabilities of the EPDS and the PHQ-9 for screening antepartum and postpartum depression: a multigroup confirmatory factor analysis
por: Stefana, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_97d6d3e6j8ov427h1be55kas6r